Gadolinium-Based Contrast Agents & Exposure in Pregnancy

    Basic Details
    Status
    Complete
    Last Updated
    Tuesday, December 19, 2017
    Health Outcome(s)
    exposure in pregnancy
    Purpose
    Drug Use
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No
    Regulatory Determination / Use

    Advisory Committee Presentation & FDA Drug Safety Communication